News | July 06, 2012

Lantheus Receives Grant to Develop 3-D Imaging Capsule for Colonoscopy Screenings

Award supports R&D collaboration with Israel-based Check-Cap to develop 3-D imaging capsule for colorectal cancer screening

July 6, 2012 — Lantheus Medical Imaging Inc. announced the company has been selected to receive a $300,000 Massachusetts-Israel Innovation Partnership (MIIP) grant. MIIP is a formal collaboration between the state of Israel and commonwealth of Massachusetts, focused on encouraging and supporting innovation and entrepreneurship between Massachusetts’ and Israel’s life sciences, clean energy and technology sectors. The grant is made possible by Mass. Gov. Deval Patrick, Israel’s chief scientist Avi Hasson, the U.S.-Israel Science and Technology Foundation (USISTF) and the Massachusetts Technology Collaborative.

Lantheus will receive the grant upon signing a collaboration agreement with Check-Cap LTD, a medical device company, to develop and manufacture a novel, noninvasive 3-D imaging capsule to screen for polyps and lesions associated with colorectal cancer. Check-Cap LTD, which is based in Mount Carmel, Israel, is being awarded a grant from the Office of the Chief Scientist in Israel. Colorectal cancer is the second leading cause of cancer death in the United States and accounts for eight percent of cancer deaths worldwide. Early detection of polyps dramatically increases the chance for survival; however it is estimated that only half of people over the age of 50, for whom screening is recommended, currently undergo routine colonoscopies.

“We are pleased to have been selected to receive this important new grant that enables us to collaborate with Check-Cap on an innovative imaging product that can potentially change the way colon cancer is detected,” said Don Kiepert, president and CEO, Lantheus Medical Imaging. “As a global leader in diagnostic imaging, Lantheus is dedicated to providing physicians with breakthrough tools to enhance patient care. Teaming up with Check-Cap to develop and manufacture a cutting-edge imaging capsule further advances this ongoing commitment.”

“With their rich heritage in pioneering innovative imaging solutions to improve the detection of human disease, Lantheus is an ideal partner for this exciting initiative,” said Guy Neev, CEO, Check-Cap. “Despite being 90 percent curable with early detection, colon cancer remains the second-most deadly cancer in the Western world. Our unique imaging capsule may increase colorectal screening compliance without compromising screening accuracy, and has the potential to reduce the high patient mortality associated with this disease.”

For more information:

Related Content

Check-Cap Announces Interim Results of European Study of C-Scan System Version 3
News | Colonoscopy Systems | September 04, 2018
Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an...
American Cancer Society Updates Colorectal Cancer Screening Guideline
News | Colonoscopy Systems | May 30, 2018
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at...
FDA Approves Updated Design for Recalled Pentax Duodenoscope
News | Colonoscopy Systems | February 08, 2018
February 8, 2018 – The U.S.
Infrared Colitis Screening Blood Test Could Reduce Dependence on Colonoscopy
News | Colonoscopy Systems | August 31, 2017
August 31, 2017 — A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheape
Insurance Coverage for CT Colonography Increases Likelihood of Screening
News | Colonoscopy Systems | July 12, 2017
People with insurance policies that cover computed tomography (CT) colonography for colorectal cancer screening are...
CT colonography (CTC) allows visualization of the entire colon in one image

CT colonography (CTC) allows visualization of the entire colon in one image. Photo courtesy of Judy Yee, M.D.

Feature | Computed Tomography (CT) | July 05, 2017 | By Jeff Zagoudis
Computed tomography colonography (CTC), also known as virtual colonoscopy, offers a noninvasive alternative to...
Technology | Colonoscopy Systems | March 27, 2017
March 27, 2017 — Bracco Diagnostics Inc. announced the launch of its PROTOCO2L TOUCH Colon Insufflator.
CT colonography, patient and provider groups, Congress, screening, H.R. 1298
News | Colonoscopy Systems | March 02, 2017
Major colorectal cancer care advocacy groups and medical societies have released a statement strongly urging Congress...